SCHEMBL31337

SCHEMBL31337

COC(O)COC1(C(N)=O)CCCCC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28559321 0.75
SCHEMBL19135 0.74 LMNA (0.34) LMNA
SCHEMBL9568683 0.72 LMNA (0.40) LMNA
SCHEMBL30926 0.70 LMNA (0.34) LMNA
SCHEMBL2771351 0.69 LMNA (0.37) LMNA
SCHEMBL9188033 0.66 CYP2C19 (0.33) LMNA
SCHEMBL12605383 0.65
SCHEMBL9790493 0.65 LMNA (0.33) LMNA
SCHEMBL28425488 0.65 CYP19A1 (0.34) LMNA
SCHEMBL11283447 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608669-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-07-03 EP claimed
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO claimed